Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Di Pastena F, Pond G, Tsakiridis EE, Gouveia A, Ahmadi E, Biziotis OD, Ali A, Swaminath A, Okawara G, Ellis PM, Abdulkarim B, Ahmed N, Robinson A, Roa W, Valdes M, Kavsak P, Wierzbicki M, Wright J, Steinberg G, Tsakiridis T.
Di Pastena F, et al. Among authors: ahmadi e.
Radiat Oncol. 2024 Nov 7;19(1):155. doi: 10.1186/s13014-024-02546-y.
Radiat Oncol. 2024.
PMID: 39511611
Free PMC article.
Clinical Trial.